US$ 24.95
l carnitine and kidneys Practice recommendations for the use of L-Carnitine in dialysis-related disorder National Kidney Foundation Carnitine Consensus Conference InClover Kidney – Bladder and
Description
Zarrinpar A, Chaix A, Xu ZZ, Chang MW, Marotz CA, Saghatelian A, Knight R, and Panda S

EGCG has shown potential in cardiovascular therapy when combined with standard treatments like statins or antihypertensive medications

Magnesium, little known but possibly relevant: a link between NASH and related comorbidities

Peng S, Hou X, Liu J, Huang F

Make It Fun

Here we review a few select neuropeptides that have either been shown to impact or have the potential to impact the pathogenesis and progression of either asthma, COPD, or CF
